DOD Biotech PCL

DOD Biotech PCL Receivables

The Accounts Receivable of DOD Biotech PCL (DOD.BK) as of Nov 5, 2026 is 39.05 M THB. In the previous year, Accounts Receivable was 315.37 M THB — a change of -87.62% (lower).

Receivables

39.05 MTHB

YoY

-87.62%

Last updated:

Accounts Receivable of DOD Biotech PCL is 2022 39.05 M THB. Accounts Receivable of DOD Biotech PCL was 2021 315.37 M THB. It decreases by -87.62% lower compared to the previous year.

The DOD Biotech PCL Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2015
39.85 M THB
Jan 1, 2016
40.42 M THB
Jan 1, 2017
50.76 M THB
Jan 1, 2018
63.12 M THB
Jan 1, 2019
215.95 M THB
Jan 1, 2020
263.19 M THB
Jan 1, 2021
315.37 M THB
Jan 1, 2022
39.05 M THB
The DOD Biotech PCL Receivables history
YEARReceivablesYoY
39.05 MTHB-87.62%
315.37 MTHB+19.83%
263.19 MTHB+21.87%
215.95 MTHB+242.11%
63.12 MTHB+24.36%
50.76 MTHB+25.58%
40.42 MTHB+1.43%
39.85 MTHB+450.37%
7.24 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DOD Biotech PCL stock

Accounts Receivable of DOD Biotech PCL is 39.05 M THB in 2022.

Accounts Receivable of DOD Biotech PCL changed from 315.37 M THB to 39.05 M THB, representing a -87.62% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's DOD Biotech PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — DOD Biotech PCL

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — DOD Biotech PCL